Plant Health Care PLC Progress with PREtec field trials in Brazil
15 Agosto 2019 - 01:01AM
RNS Non-Regulatory
TIDMPHC
Plant Health Care PLC
15 August 2019
15 August 2019
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Progress with PREtec field trials in Brazil
Plant Health Care(R) , a leading provider of novel
patent-protected biological products to global agriculture markets,
is pleased to provide the following update in relation to the
2018/19 field trials of the PREtec peptide PHC279 for the control
of Asian Soybean Rust (ASR) a potentially devastating disease that
regularly affects soybean yields in Brazil.
Highlights:
- PHC279 significantly improved ASR control of foliar fungicide
programmes, even in fields facing heavy disease pressure.
- Up to 16% increase of soybean yields when PHC279 was applied as a seed treatment.
- Up to 45% increase in the effectiveness of foliar fungicide
treatments when seeds had been treated with PHC279.
- Plant Health Care is now moving to register and manufacture
PHC279 for launch into soybeans in Brazil as a seed treatment for
ASR control.
Brazil is the world's largest exporter of soybeans, with some 36
million hectares (89 million acres) planted in 2018. One of the
challenges of producing soybeans in Brazil is ASR, which is a
potentially devastating disease. Growers spent $2.1 billion in 2017
on soybean fungicides in Brazil.
Plant Health Care's PREtec peptides stimulate the plant to
defend itself. Derived from natural proteins, these proprietary
peptides are a novel, environmentally friendly approach to
protecting crops and increasing yields, compatible with mainstream
agricultural practice.
The Company has been trialling the lead peptide PHC279 in Brazil
since 2017 under various types of applications. In this year's
crop, the Company focused on trials where PHC279 was applied as a
seed treatment to soybeans. In contrast, the main focus in the
previous year was on mixtures with fungicides applied as a foliar
treatment by spraying onto the leaves of plants.
In independent trials, carried out by PLANTEC, a major contract
research organisation in Brazil, PHC279 significantly improved ASR
control of foliar fungicide programmes, even in fields facing heavy
disease pressure. Disease control was improved by up to 45% when
PHC279 was applied as a seed treatment. In addition, yields of
soybeans were increased by up to 16% when compared with foliar
fungicide programs alone. These results provide increasing support
for the acceptance of PHC279 as a compelling tool to combat
ASR.
Based on these positive results, Plant Health Care intends to
move forward to commercialise PHC279 in Brazil. The Company intends
to seek a fast track product registration and is making plans to
produce PHC279 at commercial scale.
Paulo Fedato, Director of Research and Experimentation at
PLANTEC, said: "I am very excited to see Plant Health Care
continuing with the development of PHC 279. Based on the results
seen in PLANTEC's fields I am confident that it will be a great
tool to help growers managing the difficult problem of ASR."
Jeff Tweedy, COO of Plant Health Care, said "After two years of
trials, we are extremely encouraged with the performance of PHC279
applied as a seed treatment for ASR control. We see this as a
valuable technology for the Brazilian soybean growers. This is
further demonstration of the value of the PREtec platform and has
given PHC the confidence to move forward with the registration and
commercialization of this new technology. The Company continues to
work with more than six partners, who are testing peptides on many
crops around the world, in markets worth more than $5 billion. With
the registration of our first peptides progressing in USA and the
scale-up of manufacturing started, we look forward to delivering
this novel technology directly to markets in USA, Brazil and other
countries."
For further information, please contact:
Plant Health Care plc
Chris Richards, Executive Chairman and Interim CEO Tel: +44 7795 294 300
Jeff Tweedy, COO Tel: +1 919 926 1600
Arden Partners plc - Broker and Nomad
John Llewellyn-Lloyd / Dan Gee-Summons (Corporate Finance) Tel: +44 (0) 20 7614 5900
Fraser Marshall (Equity Sales)
Company website: www.planthealthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAPIMLTMBABBRL
(END) Dow Jones Newswires
August 15, 2019 02:01 ET (06:01 GMT)
Plant Health Care (LSE:PHC)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Plant Health Care (LSE:PHC)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024